Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy. Issue 9 (14th August 2006)

• Record Type: Journal Article
• Authors: Klingenberg, R; Zugck, C; Becker, R; Schellberg, D; Heinze, G; Kell, R; Remppis, A; Schoels, W; Katus, H A; Dengler, T J
• Is Part Of: Heart. Volume 92:Issue 9(2006)
• Page Start: 1323
• Page End: 1324
• Publication Date: 2006-08-14
• Subjects: AVID, Antiarrhythmics Versus Implantable Defibrillators -- CHF, congestive heart failure -- ICD, implantable cardioverter defibrillator -- LVEF, left ventricular ejection fraction -- MUSTT, Multicenter Unsustained Tachycardia Trial -- NT-proBNP, N-terminal pro-brain natriuretic peptide -- NYHA, New York Heart Association -- RR, relative risk -- SCD, sudden cardiac death -- VT, ventricular tachycardia; Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/hrt.2005.076117
• Languages: English
• ISSNs: 1355-6037